methylenedioxyamphetamine造句

• The coroner's report found traces of methylenedioxyamphetamine, similar to Ecstasy, in his bloodstreatm.
• MDMA likely emerged as a substitute for its analog methylenedioxyamphetamine ( MDA ), a drug at the time popular among users of psychedelics
• Tablets sold as ecstasy sometimes contain 3, 4-methylenedioxyamphetamine ( MDA ), 3, 4-methylenedioxyethylamphetamine ( MDEA ), other amphetamine derivatives, caffeine, opiates, or painkillers.
• On 7 June, the PNP Crime Laboratory confirmed that the amphetamine-based metabolites " para "-Methoxyamphetamine and methylenedioxyamphetamine were found on the bodies of Migawa and Miller, in addition to traces of methylenedioxycathinone found on Migawa.
• Specific examples include levodopa ( when used in the long term, as in Parkinson's disease ), fluoxetine, metoclopramide, lithium, cocaine, venlafaxine, citalopram, fluvoxamine, methylenedioxyamphetamine ( MDA ), methylphenidate ( used in attention deficit hyperactive disorder ), and gamma-hydroxybutyric acid ( GHB ) and similar gamma-aminobutyric acid-inducing analogues such as phenibut.
• "' 2-Methyl-3, 4-methylenedioxyamphetamine "'( "'2-methyl-MDA "') is an entactogen and MDA, although it is not as potent as 5-methyl-MDA . However, it is slightly more selective for serotonin over dopamine and norepinephrine release in comparison to 5-methyl-MDA.
• Many substituted phenethylamines are psychoactive drugs which belong to a variety of different drug classes, including central nervous system stimulants ( e . g ., amphetamine ), hallucinogens ( e . g ., 2, 5-dimethoxy-4-methylamphetamine ), entactogens ( e . g ., 3, 4-methylenedioxyamphetamine ), appetite suppressants ( e . g . phentermine ), nasal decongestants and bronchodilators ( e . g ., pseudoephedrine ), antidepressants ( e . g . bupropion ), antiparkinson agents ( e . g ., selegiline ), and vasopressors ( e . g ., ephedrine ), among others.
• "' Difluoromethylenedioxyamphetamine "'( "'DiFMDA "') is a substituted derivative of 3, 4-methylenedioxyamphetamine ( MDA ), which was developed by Daniel Trachsel and coworkers, along with the corresponding fluorinated derivatives of MDMA, MDEA, BDB and MBDB, with the aim of finding a non-neurotoxic drug able to be used as a less harmful substitute for entactogenic drugs such as MDMA . Since a major route of the normal metabolism of these compounds is scission of the methylenedioxy ring, producing neurotoxic metabolites such as alpha-methyldopamine, it was hoped that the difluoromethylenedioxy bioisostere would show increased metabolic stability and less toxicity.